In situ expression of angiopoietins in astrocytomas identifies angiopoietin-2 as an early marker of tumor angiogenesis

Experimental Neurology

Volumn 159, Issue 2, 1999, Pages 391-400

  Zagzag, David ^a   Hooper, Andrea ^a   Friedlander, David R ^a   Chan, Wai ^a   Holash, Jocelyn ^b   Wiegand, Stanley J ^b   Yancopoulos, George D ^b   Grumet, Martin ^a  

^a NEW YORK UNIVERSITY MEDICAL CENTER   (United States)

^b REGENERON PHARMACEUTICALS INC   (United States)

Author keywords

Angiogenesis; Angiopoietins; Astrocytomas; Endothelial cells; Extracellular matrix; Smooth muscle cells pericytes

Indexed keywords

GROWTH FACTOR; LIGAND; MESSENGER RNA; TUMOR MARKER; TYROSINE KINASE RECEPTOR;

ANGIOGENESIS; ARTICLE; ASTROCYTOMA; CELL INTERACTION; CONTROLLED STUDY; ENDOTHELIUM CELL; HUMAN; HUMAN CELL; HUMAN TISSUE; HYPERPLASIA; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; IN SITU HYBRIDIZATION; NEOVASCULARIZATION (PATHOLOGY); PERICYTE; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; SMOOTH MUSCLE FIBER;

EID: 0032843659     PISSN: 00144886     EISSN: None     Source Type: Journal    
DOI: 10.1006/exnr.1999.7162     Document Type: Article

References (50)

1. Antonelli-Oridge A., Saunders K. B., Smith S. R., D'Amore P. A. An activated form of transforming growth factor β is produced by cocultures of endothelial cells and pericytes. Proc. Natl. Acad. Sci. USA. 86:1989;4544-4548.
2. Brem S., Cotran R., Folkman J. Tumor angiogenesis: A quantitative method for histologic grading. J. Natl. Cancer Inst. 48:1972;347-356.
3. Cogan D. G., Toussaint D., Kuwabara D. Retinal vascular patterns: IV. Diabetic retinopaty. Arch. Ophthalmol. 66:1961;366-378.
4. D'Amore P. A., Smith S. R. Growth factors effects on cells of the vascular wall: A survey. Growth Factors. 8:1993;64-75.
5. Davis S., Aldrich T. H., Jones P. F., Acheson A., Compton L. D., Jain V., Ryan T. E., Bruno J., Radziejewski C., Maisonpiere C. P., Yancopoulous D. G. Isolation of angiopoietin-1, a ligand for the TIE2 receptor, by secretion-trap expression cloning. Cell. 87:1996;1161-1169.
6. Dumont D. J., Yamaguchi T. P., Conlon R. A., Rossant J., Breitman M. L. tek, a novel tyrosine kinase gene located on mouse chromosome 4, is expressed in endothelial cells and their presumptive precursors. Oncogene. 7:1992;1471-1480.
7. Dumont D. J., Gradwohl G., Fong G.-H., Puri M. C., Gertsenstein M., Auerbach A., Breitman M. L. Dominant-negative and targeted null mutations in the endothelial receptor tyrosine kinase, tek, reveal a critical role in vasculogenesis of the embryo. Genes Dev. 8:1994;1897-1909.
8. Enholm B., Paavonen K., Ristimaki A., Kumar V., Gunji Y., Klefstrom J., Kivinen L., Laiho M., Olofsson B., Joukov V., Eriksson U., Alitalo K. Comparison of VEGF, VEGF-B, VEGF-C and Ang-1 mRNA regulation by serum, growth factors, oncoproteins and hypoxia. Oncogene. 14:1997;2475-2483.
9. 1. Cancer Res. 52:1992;4821-4823.
10. Hatva E., Kaipainen A., Mentula P., Jaaskelainen J., Paetau A., Haltia M., Alitalo K. Expression of endothelial cell-specific receptor tyrosine kinases and growth factors in human brain tumors. Am. J. Pathol. 146:1995;368-378.
11. Herman I. M., D'Amore P. A. Microvascular pericytes contain muscle and nonmuscle actin. J. Cell Biol. 101:1985;43-52.
12. Hermansson M., Nister M., Betsholz C., Heldin C. H., Westermark B., Funa K. Endothelial cell hyperplasia in human glioblastoma: Coexpression of mRNA for platelet-derived growth factor (PDGF) B chain and PDGF receptor suggests autocrine growth stimulation. Proc. Natl. Acad. Sci. USA. 85:1988;7748-7752.
13. Holash J., Maisonpierre P. C., Compton D., Boland P., Alexander C. R., Zagag D., Yancopoulos G. D., Wiegand S. J. Vessel cooption, regression, and growth in tumors mediated by angiopoietins and VEGF. Science. 284:1999;1994-1998.
14. Kaipainen A., Vlaykova T., Hatva E., Bohling T., Jekunen A., Pyrhonen S., Alitalo K. Enhanced expression of the tie receptor tyrosine kinase messenger RNA in the vascular endothelium of metastatic melanomas. Cancer Res. 54:1994;6571-6577.
15. Kleihues P., Burger P. C., Scheithauer B. W. The new WHO classification of brain tumours. Brain Pathol. 3:1993;255-268.
16. Koblizek T. I., Weiss C., Yancopoulos G. D., Deutsch U., Risau W. Angiopoietin-1 induces sprouting angiogenesis in vitro. Curr. Biol. 8:1998;528-532.
17. Lafleur D. W., Chiang J. L., Fagin J. A., Schwartz S. M., Shah P. K., Walner K., Forrester J. S., Sharifi B. G. Aortic smooth muscle cells interact with tenascin-C through its fibrinogen-like domain. J. Biol. Chem. 272:1997;32798-32803.
18. Lin P., Buxton J. A., Acheson A., Radziejewski C., Maisonpierre P. C., Yancopoulos G. D., Channon K. M., Hale L. P., Dewhirst M. W., George S. E., Peters K. G. Antiangiogenic gene therapy targeting the endothelium-specific receptor tyrosine kinase Tie2. Proc. Natl. Acad. Sci. USA. 95:1998;8829-8834.
19. Luna L. G. Manual of Histologic Staining Methods of Armed Forces Institute of Pathology. 1968;McGraw-Hill, New York.
20. Maisonpierre P. C., Suri C., Jones P. F., Bartunkova S., Weigand J. S., Radziejewski C., Compton D., McClain J., Aldrich T. H., Papadopoulos N., Daly T. J., Davis S., Sato T. N., Yancopoulos G. D. Angiopoietin-2, a natural antagonist for Tie2 that disrupts in vivo angiogenesis. Science. 277:1997;55-60.
21. Mandriota S. J., Pepper M. S. Regulation of angiopoietin-2 mRNA levels in bovine microvascular endothelial cells by cytokines and hypoxia. Circ. Res. 83:1998;852-859.
22. Nagano N., Sasaki H., Aoyagi M., Hirakawa K. Invasion of experimental rat tumor: Early morphological changes following microinjection of C6 glioma cells. Acta Neuropathol. 86:1993;117-125.
23. Nehls V., Drenckhahn D. The versatility of microvascular pericytes: From mesenchyme to smooth muscle. Histochemistry. 99:1993;1-12.
24. Nicosia R. F., Villaschi S. Rat aortic smooth muscle cells become pericytes during angiogenesis in vitro. Lab. Invest. 73:1995;658-666.
25. Orlidge A., D'Amore P. A. Inhibition of capillary endothelial cell growth by pericytes and smooth muscle cells. J. Cell Biol. 105:1987;1455-1462.
26. Partanen J., Armstrong E., Makela T. P., Korhonen J., Sandberg M., Renkonen R., Knuutila S., Huebner K., Alitalo K. A novel endothelial cell surface receptor tyrosine kinase with extracellular epidermal growth factor homology domains. Mol. Cell Biol. 12:1992;1698-1707.
27. Pertovaara L., Kaipainen A., Mustonen T., Orpana A., Ferrara N., Saksela O., Alitalo K. Vascular endothelial growth factor is induced in response to transforming growth factor-β in fibroblastic and epithelial cells. J. Biol. Chem. 269:1994;6271-6274.
28. Peters K. G., Coogan A., Berry D., Marks J., Iglehart J. D., Kontos C. D., Rao P., Sankar S., Trogan E. Expression of Tie2/Tek in breast tumour vasculature provides a new marker for evaluation of tumour angiogenesis. Br. J. Cancer. 77:1998;51-56.
29. Plate K. H., Breier G., Weich H. A., Risau W. Vascular endothelial growth factor is a potential tumour angiogenesis factor in human gliomas vivo. Nature. 359:1992;845-848.
30. Plate K. H., Breier G., Farrell C. L., Risau W. Platelet-derived growth factor receptor-beta is induced during tumor development and upregulated during tumor progression in endothelial cells in human gliomas. Lab. Invest. 67:1992;529-534.
31. Rhodin J. A. G. Architecture of the vessel wall. Handbook of Physiology - The Cardiovascular System. 1980;Waverly Press, Baltimore. p. 1-30.
32. Robison W. G., McCaleb M. L., Field L. G. Degenerated intramural pericytes ("ghost cells") in the retinal capillaries of diabetic rats. Curr. Eye Res. 10:1991;339-350.
33. Rojiani A. M., Dorovini-Zis K. Glomeruloid vascular structures in glioblastoma multiforme: An immunohistochemical and ultrastructural study. J. Neurosurg. 85:1996;1078-1084.
34. Sato Y., Rifkin D. B. Inhibition of endothelial cell movement by pericytes and smooth muscle cells: activation of latent transforming growth factor β-1-like molecule by plasmin during co-culture. J. Cell Biol. 109:1989;309-315.
35. Sato T., Qin Y., Kozak C. A., Audus K. L. Tie-1 and tie-2 define another class of putative receptor tyrosine kinase genes expressed in early embryonic vascular system. Proc. Natl. Acad. Sci. USA. 90:1993;9355-9358.
36. Sato T. N., Tozawa Y., Deutsch U., Wolburg-Buchholz K., Fijiwara Y., Gendron-Maguire M., Gridley T., Wolburg H., Risau W., Qin Y. Distinct roles of the receptor tyrosine kinases Tie-1 and Tie-2 in blood vessel formation. Nature. 376:1995;70-74.
37. Schilingmann R. O., Rietveld R. J. R., Kwaspen F., van der Kerkhof F. P. C., de Waal M. W., Ruier D. J. Differential expression of markers for endothelial cells pericytes, and basal lamina in the microvasculature of tumors and granulation tissue. Am. J. Pathol. 138:1991;1335-1347.
38. Shepro D., Morel N. M. L. Pericytes physiology. FASEB J. 7:1993;1031-1038.
39. Shweiki D., Itin A., Soffer D., Keshet E. Vascular endothelial growth factor induced by hypoxia may mediate hypoxia-initiated angiogenesis. Nature. 359:1992;843-845.
40. Sims D. E. Recent advances in pericyte biology - Implications for health and disease. Can. J. Cardiol. 7:1991;431-443.
41. Skalli O., Ropraz P., Tzociak A., Benzonano G., Gillessen D., Gabbiani G. A mAb against alpha-smooth muscle actin. A new probe for smooth muscle differentiation. J. Cell Biol. 103:1986;22787-22796.
42. Speiser P., Gittelsohn A. M., Patz A. Studies on diabetic retinopathy III. Influence of diabetes on intramural pericytes. Arch. Ophthalmol. 80:1968;332-337.
43. Suri C., Jones P. F., Patan S., Bartunkova S., Maisonpierre P. C., Davis S., Sato T. N., Yancopolous G. D. Requisite role of angiopoietin-1 a ligand for the TIE2 receptor, during embryonic angiogenesis. Cell. 87:1996;1171-1180.
44. Suri C., McClain J., Thurston G., McDonald D. M., Zhou H., Oldmixon E. H., Sato T. N., Yancopoulos G. D. Angiopoietin-1 promotes increased vascularization in vivo. Science. 282:1998;468-471.
45. Tsai J. C., Goldman C. K., Gillespie G. Y. Vascular endothelial growth factor in human glioma cell lines: Induced secretion by EGF, PDGF-BB and bFGF. J. Neurosurg. 82:1995;864-873.
46. Wesseling P., Schlingemann R. O., Rietveld F. J. R., Link M., Burger P. C., Ruiter D. J. Early and extensive contribution of pericytes/vascular smooth muscle cells to microvascular proliferation in glioblastoma multiforme: An immuno-light and immuno-electron microscopic study. J. Neuropathol. Exp. Neurol. 54:1995;304-310.
47. Wiener H. The role of growth factor receptors in central nervous system development and neoplasia. Neurosurgery. 37:1995;179-193.
48. Williams S. Angiogenesis in three-dimensional cultures. Lab. Invest. 69:1993;491-493.
49. Zagzag D. Angiogenic growth factors in neural embryogenesis and neoplasia. Am. J. Pathol. 146:1995;293-309.
50. Zagzag D., Friedlander D. R., Dosik J., Chikramane S., Chan W., Greco M. A., Dorovini-Zis K., Grumet M. Tenascin-C expression in angiogenic vessels of human astrocytomas and by human brain endothelial cells in vitro. Cancer Res. 56:1996;182-189.